Viewing StudyNCT05696548



Ignite Creation Date: 2024-05-06 @ 6:31 PM
Last Modification Date: 2024-10-26 @ 2:50 PM
Study NCT ID: NCT05696548
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-21
First Post: 2023-01-13

Brief Title: Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer NAVIGATION
Sponsor: National Cancer Center Hospital East
Organization: National Cancer Center Hospital East

Conditions & Keywords Data

Conditions:
Name
Anaplastic Thyroid Cancer
Keywords:
Name View
Anaplastic Thyroid Cancer View
Nivolumab View
Lenvatinib View